Literature DB >> 25523594

Microglia in the tumor microenvironment: taking their TOLL on glioma biology.

David H Gutmann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25523594      PMCID: PMC4288529          DOI: 10.1093/neuonc/nou346

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.

Authors:  Xian-zong Ye; Sen-lin Xu; Yan-hong Xin; Shi-cang Yu; Yi-fang Ping; Lu Chen; Hua-liang Xiao; Bin Wang; Liang Yi; Qing-liang Wang; Xue-feng Jiang; Lang Yang; Peng Zhang; Cheng Qian; You-hong Cui; Xia Zhang; Xiu-wu Bian
Journal:  J Immunol       Date:  2012-06-04       Impact factor: 5.422

Review 2.  The ecology of brain tumors: lessons learned from neurofibromatosis-1.

Authors:  W W Pong; D H Gutmann
Journal:  Oncogene       Date:  2010-11-15       Impact factor: 9.867

3.  CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

Authors:  Janka Held-Feindt; Kirsten Hattermann; Susanne Sebens Müerköster; Hanna Wedderkopp; Friederike Knerlich-Lukoschus; Hendrik Ungefroren; H Maximilian Mehdorn; Rolf Mentlein
Journal:  Exp Cell Res       Date:  2010-02-23       Impact factor: 3.905

4.  A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.

Authors:  Jing Zhang; Susobhan Sarkar; Rowena Cua; Yan Zhou; Walter Hader; V Wee Yong
Journal:  Carcinogenesis       Date:  2011-12-08       Impact factor: 4.944

5.  Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Axinia Döring; Franz J Zemp; Claudia Silva; Xueqing Lun; Xiuling Wang; John Kelly; Walter Hader; Mark Hamilton; Philippe Mercier; Jeff F Dunn; Dave Kinniburgh; Nico van Rooijen; Stephen Robbins; Peter Forsyth; Gregory Cairncross; Samuel Weiss; V Wee Yong
Journal:  Nat Neurosci       Date:  2013-12-08       Impact factor: 24.884

6.  Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.

Authors:  Girish C Daginakatte; Scott M Gianino; Nina W Zhao; Alexander S Parsadanian; David H Gutmann
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.

Authors:  Winnie W Pong; Samantha B Higer; Scott M Gianino; Ryan J Emnett; David H Gutmann
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

Review 8.  Exploiting ecological principles to better understand cancer progression and treatment.

Authors:  David Basanta; Alexander R A Anderson
Journal:  Interface Focus       Date:  2013-08-06       Impact factor: 3.906

9.  Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Authors:  Michael Platten; Alexandra Kretz; Ulrike Naumann; Steffen Aulwurm; Kensuke Egashira; Stefan Isenmann; Michael Weller
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

10.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

View more
  14 in total

1.  CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages.

Authors:  Ishani De; Megan D Steffen; Paul A Clark; Clayton J Patros; Emily Sokn; Stephanie M Bishop; Suzanne Litscher; Vilena I Maklakova; John S Kuo; Fausto J Rodriguez; Lara S Collier
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

Review 2.  Pediatric low-grade gliomas: implications of the biologic era.

Authors:  Roger J Packer; Stephan Pfister; Eric Bouffet; Robert Avery; Pratiti Bandopadhayay; Miriam Bornhorst; Daniel C Bowers; David Ellison; Jason Fangusaro; Nicholas Foreman; Maryam Fouladi; Amar Gajjar; Daphne Haas-Kogan; Cynthia Hawkins; Cheng-Ying Ho; Eugene Hwang; Nada Jabado; Lindsay B Kilburn; Alvaro Lassaletta; Keith L Ligon; Maura Massimino; Schouten-van Meeteren; Sabine Mueller; Theo Nicolaides; Giorgio Perilongo; Uri Tabori; Gilbert Vezina; Katherine Warren; Olaf Witt; Yuan Zhu; David T Jones; Mark Kieran
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

3.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.

Authors:  Mamatha Bangalore Nijaguna; Vikas Patil; Serge Urbach; Shivayogi D Shwetha; Kotha Sravani; Alangar S Hegde; Bangalore A Chandramouli; Arimappamagan Arivazhagan; Philippe Marin; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

4.  Hormones and immunity in cancer: are thyroid hormones endocrine players in the microglia/glioma cross-talk?

Authors:  Cristiana Perrotta; Clara De Palma; Emilio Clementi; Davide Cervia
Journal:  Front Cell Neurosci       Date:  2015-06-23       Impact factor: 5.505

Review 5.  Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors.

Authors:  Giuseppina D'Alessandro; Cristina Limatola; Myriam Catalano
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 6.  Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.

Authors:  Qing Zhang; Fusheng Liu
Journal:  Cell Death Dis       Date:  2020-06-25       Impact factor: 8.469

7.  Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.

Authors:  Zachary S Buchwald; Sibo Tian; Michael Rossi; Geoffrey H Smith; Jeffrey Switchenko; Jennifer E Hauenstein; Carlos S Moreno; Robert H Press; Roshan S Prabhu; Jim Zhong; Debra F Saxe; Stewart G Neill; Jeffrey J Olson; Ian R Crocker; Walter J Curran; Hui-Kuo G Shu
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

Review 8.  Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment.

Authors:  Guidong Zhu; Qing Zhang; Junwen Zhang; Fusheng Liu
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

9.  Evaluation of Consistency in Spheroid Invasion Assays.

Authors:  Liliana R Cisneros Castillo; Andrei-Dumitru Oancea; Christian Stüllein; Anne Régnier-Vigouroux
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

Review 10.  Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.

Authors:  Thomas N Wight; Inkyung Kang; Stephen P Evanko; Ingrid A Harten; Mary Y Chang; Oliver M T Pearce; Carys E Allen; Charles W Frevert
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.